GILD and GSK Related Headlines
Go Back- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
- 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
